Wishing you all the joys of the season! 
North America Blood Gas and Electrolyte Analyzer Market Forecast to 2031
North America Blood Gas and Electrolyte Analyzer Market Forecast to 2031 – Regional Analysis – by Product (Blood Gas Analyzer, Electrolyte Analyzer, Combined Analyzer, and Others) and End User (Hospitals and Clinics, Clinical and Diagnostic Laboratories, Homecare, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Number of Patients in Emergency Units of Hospitals Fuels North America Blood Gas and Electrolyte Analyzer Market
The rising prevalence of diabetes, cancer, heart disease, and other chronic conditions propels the requirement for hospital emergency rooms (ER). Hospital emergency rooms offer vital medical care for patients affected by severe chronic conditions who need immediate attention and medical intervention. These services are complex, with each part being crucial to providing care. The primary objective of emergency medical services is immediately treating medical, surgical, and obstetric problems. The increasing number of patients seeking care in emergency hospital emergency units positively impacts the demand for blood gas and electrolyte analyzers. According to the World Health Organization (WHO), around 150 million patients visit hospital emergency rooms across the world annually. The US records about 139.8 million ER visits per year, according to data released by the CDC in 2023. In addition, there was a 7.4% rise in ED visits in California between 2011 and 2021. As emergency departments face mounting pressure to deliver rapid and accurate assessments of critically ill patients, timely diagnostic information on blood gas values, electrolyte levels, and acid-base balance becomes paramount. Blood gas and electrolyte analyzers provide on-the-spot diagnostic data for evaluating and managing patients affected by respiratory distress, metabolic abnormalities, or critical conditions. The ability of these analyzers to provide real-time insights into a patient’s oxygenation status, acid-base equilibrium, and electrolyte levels is crucial for guiding resuscitative measures and optimizing clinical outcomes in emergency settings.
The growing demand for blood gas and electrolyte analyzers in emergency units drives advancements in technology, such as portable and point-of-care devices, that enable rapid testing at the patient’s bedside. These compact analyzers enhance workflow efficiency and improve patient outcomes by facilitating prompt diagnosis and treatment initiation. As hospitals prioritize enhancing emergency care services to meet the needs of a rising patient population, the blood gas and electrolyte analyzers market is witnessing increased adoption of technologically advanced solutions tailored to the urgent and critical care setting.
North America Blood Gas and Electrolyte Analyzer Market Overview
The North America blood gas and electrolyte analyzer market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America blood gas and electrolyte analyzer market in 2023. The growth is driven by increasing public awareness regarding cardiovascular diseases and growing research and collaboration to explore innovative therapeutic applications in the blood gas and electrolyte analyzer market. The market for blood gas and electrolyte analyzer test kits in North America is projected to spur with the presence of various key players in the market. In addition, the adoption of medical devices in healthcare operations for improving quality and reducing costs augments the growth of the blood gas and electrolyte analyzer market in the region.
North America Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
North America Blood Gas and Electrolyte Analyzer Market Segmentation
The North America blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the North America blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the North America blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the North America blood gas and electrolyte analyzer market is segmented into the US, Canada, and Mexico. The US dominated the North America blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the North America blood gas and electrolyte analyzer market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights’ research, the North America blood gas and electrolyte analyzer market was valued at US$ 936.97 million in 2023 and is expected to reach US$ 1,405.02 million by 2031, registering a CAGR of 5.2% from 2023 to 2031. Automation and artificial intelligence in blood gas & electrolyte analyzer and new product launches & approvals are among the critical factors attributed to drive the North America blood gas and electrolyte analyzer market growth.
Automation in blood gas and electrolyte analyzer entails the use of robotic systems, sample handling mechanisms, and automated workflows to streamline testing processes, reduce manual intervention, and enhance result turnaround times. The automation improves laboratory productivity and minimizes the risk of human error, ensuring consistent and reliable diagnostic outcomes for healthcare providers.
Artificial intelligence is poised to revolutionize blood gas and electrolyte analysis by enabling machine learning algorithms, predictive analytics, and smart data interpretation capabilities within diagnostic devices. AI-driven solutions can optimize test result interpretation, identify patterns and trends in patient data, and provide valuable insights for clinical decision-making. By leveraging AI algorithms, blood gas and electrolyte analyzers can offer enhanced diagnostic accuracy, personalized treatment recommendations, and predictive modeling for patient care management. The combination of automation and AI in blood gas and electrolyte analyzers will elevate the standards of diagnostic testing, enabling rapid, precise, and data-driven medical assessments. Automated sample processing, intelligent result interpretation, and predictive analytics will empower healthcare providers with comprehensive insights into a patient’s metabolic status, electrolyte balance, and acid-base equilibrium, fostering informed clinical decisions and personalized treatment strategies. Additionally, integrating connectivity and digital health solutions will allow for seamless data transfer, remote monitoring, and real-time collaboration between healthcare teams, optimizing efficient patient care delivery and treatment outcomes. Therefore, the future of the blood gas and electrolyte analyzer market is set to be significantly shaped by the integration of automation and AI technologies, started in a new trend of efficiency, accuracy, and innovation in diagnostic testing.
On the contrary, high cost of analysers hamper the growth of North America blood gas and electrolyte analyzer market.
Based on product, the North America blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held 60.7% market share in 2023, amassing US$ 568.87 million. It is projected to garner US$ 870.67 million by 2031 to register 5.5% CAGR during 2023–2031.
By end user, the North America blood gas and electrolyte analyzer market is categorized into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held 64.4% share of North America blood gas and electrolyte analyzer market in 2023, amassing US$ 603.21 million. It is projected to garner US$ 921.54 million by 2031 to expand at 5.4% CAGR from 2023 to 2031.
Based on country, the North America blood gas and electrolyte analyzer market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.7% share of North America blood gas and electrolyte analyzer market in 2023. It was assessed at US$ 793.99 million in 2023 and is likely to hit US$ 1,176.00 million by 2031, registering a CAGR of 5.0% during 2023–2031.
Key players operating in the North America blood gas and electrolyte analyzer market are Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd., among others.
In May 2020, Roche launched CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm. In February 2020, Sensa Core Medical Instrumentation announced the availability of ST-200 CC Blood Gas Analyzer for hospitals, clinics and diagnostic centres through its distributor network all over the world.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America blood gas and electrolyte analyzer market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America blood gas and electrolyte analyzer market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Blood Gas and Electrolyte Analyzer Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Number of Patients in Emergency Units of Hospitals
4.1.2 Rising Adoption of Point-of-Care Diagnostics
4.2 Market Restraints
4.2.1 High Costs of Analyzers
4.3 Market Opportunities
4.3.1 New Product Launches and Approvals
4.4 Future Trends
4.4.1 Automation and Artificial Intelligence in Blood Gas and Electrolyte Analyzer
4.5 Impact of Drivers and Restraints:
5. Blood Gas and Electrolyte Analyzer Market – North America Analysis
5.1 North America Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
5.2 Blood Gas and Electrolyte Analyzer Market Forecast Analysis
6. North America Blood Gas and Electrolyte Analyzer Market Analysis – by Product
6.1 Blood Gas Analyzer
6.1.1 Overview
6.1.2 Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
6.2 Electrolyte Analyzer
6.2.1 Overview
6.2.2 Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Combined Analyzer
6.3.1 Overview
6.3.2 Combined Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7. North America Blood Gas and Electrolyte Analyzer Market Analysis – by End User
7.1 Hospitals and Clinics
7.1.1 Overview
7.1.2 Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Clinical and Diagnostic Laboratories
7.2.1 Overview
7.2.2 Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Homecare
7.3.1 Overview
7.3.2 Homecare: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Blood Gas and Electrolyte Analyzer Market – Country Analysis
8.1 North America
8.1.1 North America: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast Analysis – by Country
8.1.1.1 North America: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast Analysis – by Country
8.1.1.2 United States: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 United States: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.2.2 United States: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.3 Canada: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 Canada: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.3.2 Canada: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.4 Mexico: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Mexico: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.4.2 Mexico: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.2 Organic Growth Strategies
9.2.1 Overview
9.3 Brand Share/Revenue- 2022
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Dalko Diagnostics Private Limited
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Erba Diagnostics Mannheim GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Hoffmann-La Roche Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Medica Corporation
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Nova Biomedical Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Siemens Healthineers AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Werfen SA
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Radiometer Medical ApS
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Sensa Core Medical Instrumentation Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Research Team
11.2 Glossary of Terms
Table 1. North America Blood Gas and Electrolyte Analyzer Market Segmentation
Table 2. Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 4. Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 5. North America: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 6. United States: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 7. United States: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Canada: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 9. Canada: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. Mexico: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 11. Mexico: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 12. Recent Organic Growth Strategies in the Blood Gas and Electrolyte Analyzer Market
Table 13. Brand Share of Products for Each Company (US$ Million)
Table 14. Glossary of Terms, Blood Gas and Electrolyte Analyzer Market
Figure 1. North America Blood Gas and Electrolyte Analyzer Market Segmentation, by country
Figure 2. Blood Gas and Electrolyte Analyzer Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
Figure 5. Blood Gas and Electrolyte Analyzer Market Share (%) – by Product (2023 and 2031)
Figure 6. Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Combined Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Blood Gas and Electrolyte Analyzer Market Share (%) – by End User (2023 and 2031)
Figure 11. Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Homecare: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. North America: Blood Gas and Electrolyte Analyzer Market, by Key Country – Revenue (2023) (USD Million)
Figure 16. North America: Blood Gas and Electrolyte Analyzer Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 17. United States: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Canada: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Mexico: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
The List of Companies – North America Blood Gas and Electrolyte Analyzer Market
o Abbott Laboratories.
o Dalko Diagnostics Private Limited.
o Erba Diagnostics Mannheim GmbH.
o Hoffmann-La Roche Ltd.
o Medica Corporation.
o Nova Biomedical Corporation.
o Siemens Healthineers AG.
o Werfen SA.
o Radiometer Medical ApS.
o Sensa Core Medical Instrumentation Pvt Ltd.
You must be logged in to post a review.
Reviews
There are no reviews yet.